Palantir Drops Over 7% After Q3 Report as Multiple Wall Street Firms Maintain Buy Ratings
nashnova research
Palantir posted Q3 revenue of $2.31 billion, up 96% year-over-year and well above estimates, yet shares fell over 7% pre-market on soft bookings; seven major Wall Street firms still hold buy or overweight ratings with targets spanning $200–$262.
How strong was the quarter?
Adjusted EPS came in at $0.44 vs. the $0.41 consensus; revenue hit $2.31 billion vs. the $2.18 billion estimate.
U.S. commercial revenue surged 113% YoY to $984 million, surpassing U.S. government revenue for the first time ever. This means → Palantir is crossing from "government contractor" to "commercial AI platform" — a structural shift in its revenue mix.
Q4 revenue guidance was raised to roughly $2.65 billion, implying ~89% YoY growth — 6 percentage points faster than the Q3 high-end guide.
If the numbers beat, why did the stock sell off?
Total contract value (TCV — the aggregate dollar value of signed deals) grew just 6% YoY, far below revenue growth.
Remaining performance obligations (RPO — backlog yet to be delivered) were flat quarter-over-quarter, the first time since Q1 2023.
In plain terms = revenue is soaring, but new bookings aren't keeping up. The market is questioning whether growth can sustain, not whether the company is profitable today.
Palantir attributes the softness to shorter contract durations: clients are signing shorter deals, which mechanically shrinks per-contract dollar values.
Where does Wall Street stand?
JPMorgan set the highest target at $262, calling Palantir "the highest-quality AI-powered platform" and noting sovereign-AI demand is in its "early innings."
BofA at $255, UBS at $250, Citi at $250 — all citing AI-platform dominance and accelerating momentum.
Deutsche Bank at $240, highlighting a Rule of 40 score — a composite metric of revenue growth plus profit margin — of 158, its 13th consecutive quarterly improvement.
Morgan Stanley is the sole holdout without a buy rating, keeping equal-weight, but still raised its target from $205 to $233 — roughly 31% above the prior close.
Is the bookings weakness noise or a real signal?
Citi notes the bookings metric faces a tough base-period comparison; on a two-year compound basis, growth remains above 100%, and computed billings grew ~100% YoY. This means → over a longer window, bookings haven't actually deteriorated — last year's comparison period was simply very strong.
William Blair analyst DiPalma stresses that roughly half of Palantir's revenue comes from defense agencies, giving it stronger cycle resilience than AI supply-chain peers whose valuations have already halved.
In plain terms = the market's core debate boils down to one question — is the bookings softness a technical adjustment from shorter contracts, or an early sign that demand is cooling? Q4 earnings will be the decisive test.
市场有风险，内容仅供研究参考，不构成投资建议。